---
$id: https://graph.org.ai/products/commodity/51142542
$type: Product
source: UNSPSC
code: "51142542"
title: "Apomorphine diacetate"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Apomorphine diacetate

**UNSPSC Code**: 51142542
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent C21H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1USW70QZGV, chemically known as (6ar)-5,6,6a,7-tetrahydro-6-methyl-4h-dibenzo(de,g)quinoline-10,11-diol diacetate (ester), but more generally known as apomorphine diacetate, which bears US NIH Compound Identifier 201536. Most nations, for tariff and trade purposes, schedule apomorphine diacetate under HS 29391900 and SITC 54141. As of Q4 2014, APOMORPHINE DIACETATE remains US FDA's Preferred Term for this commodity. Apomorphine diacetate bears US NLM identifiers UMLS ID C2827080 and NCI Concept Code C83535. SMILES: CC(=O)OC1CCC2C(C1OC(=O)C)-C3CCCC4C3[C@@H](C2)N(CC4)C.

